"
NEWS / 0448

Technology

Doxycycline in Early Pregnancy Tied to Higher Risk of Pregnancy Loss

Published
Nov 12, 2026
Views
708

A University of Florida study of 224,870 pregnancies links first-trimester doxycycline to higher pregnancy loss, though causation is unproven.

Doxycycline in Early Pregnancy Tied to Higher Risk of Pregnancy Loss

Doxycycline is one of the most reflexively prescribed antibiotics in primary care, which is why a new signal about early pregnancy deserves attention. A study published Tuesday (Nov. 10) in Annals of Internal Medicine suggests that taking the drug during the first trimester is associated with a higher risk of pregnancy loss than several common alternatives.

The drug is broad-spectrum, covering a wide range of bacteria. It's often used to treat acne, respiratory infections and sexually transmitted infections like chlamydia and syphilis. Clinicians typically steer away from it in the second and third trimesters because it belongs to a class of antibiotics that binds to calcium in developing bones. Animal studies point to possible disruption of fetal bone development. Early pregnancy, by contrast, has long been a grayer area, and the existing evidence there has been mixed and thin.

"I would advise physicians to carefully consider the benefit-risk balance when prescribing doxycycline to women who are pregnant or planning a pregnancy," said Almut Winterstein, a pharmacist and drug-safety researcher at the University of Florida and the study's first author.

A higher risk than other antibiotics

The team drew on two U.S. insurance databases and analyzed 224,870 pregnancies in people ages 12 to 55. Most involved respiratory tract infections, with more than 218,230 patients treated for those, and over 6,630 treated for acne. Between conception and the end of the first trimester, about 4,385 women filled a doxycycline prescription. The rest received a different antibiotic.

Among women with respiratory infections, those given doxycycline had a 40% to 54% higher risk of pregnancy loss than those given amoxicillin, a broad-spectrum antibiotic from a different class. The size of the effect shifted between the two databases, which is worth keeping in mind.

The comparison against macrolides, the class that includes azithromycin, or "Z-Pak," told a similar story. Doxycycline users faced 39% and 36% higher risks in the two datasets.

Acne patients showed a split result. In one database, doxycycline users had a 49% higher risk of pregnancy loss than patients given clindamycin. In the second database, the difference didn't reach statistical significance. Winterstein suspects the smaller patient group in that analysis is the reason.

Taken together, the researchers estimated doxycycline was associated with seven to 11 additional pregnancy losses per 100 pregnancies, compared with the other antibiotics assessed.

woman looking at result of pregnancy test while standing in a bathroom

The researchers examined the risk associated with taking various antibiotics in the first 12 weeks of pregnancy. (Image credit: MementoJpeg via Getty Images)

What drives the risk?

Nobody knows yet how the drug might contribute to losses. The study is observational, so it can't prove doxycycline caused them. The losses included miscarriages, defined as pregnancy loss before 20 weeks, and stillbirths, which occur after the 20th week.

Luke Grzeskowiak, an associate professor and clinical pharmacist at Flinders University in Australia who wasn't involved in the work, pointed to animal data. Those studies hint that doxycycline could interfere with early placental development, making it harder for the placenta to sustain a growing pregnancy. The study authors also raised the possibility of direct effects on the embryo. Both explanations remain hypotheses. The researchers haven't shown that either mechanism operates in people.

Grzeskowiak put the baseline in perspective: "Pregnancy loss affects around one in four pregnancies and can happen for many reasons." Doxycycline exposure may add to that risk, but it doesn't mean loss will follow. The data suggests the drug is one risk factor among many.

What prescribers should weigh

Doxycycline gets prescribed before many people know they're pregnant. Grzeskowiak argues that clinicians treating women of reproductive age, especially those who are sexually active, should factor in the possibility of pregnancy when they write the script. He was clear that this isn't a case for withholding the drug. Instead, prescribers should weigh pregnancy plans and medical history when choosing treatment.

Winterstein agrees that context decides it. For a severe infection, doxycycline may still be the best option, and that infection could itself threaten a pregnancy. For milder infections, she said, safer alternatives often exist. The open question is how much of the excess risk holds up in prospective studies designed to isolate the drug's effect, and that's the work to watch next.

Source: Isha Ishtiaq · www.livescience.com

Discussion

Sign in to join the discussion.